Search - tctmd.com

Displaying 121 - 140 of 350

Sort: Relevancy | Date

News Daily News

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

Yael L. Maxwell

October 24, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Todd Neale

September 26, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

News Daily News

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

Shelley Wood

August 23, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Daily News

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

Todd Neale

May 20, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

Advertisement

Too Few Veterans Get Intensified Lipid-Lowering Therapy After Coronary Events

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

October 2022 News Roundup

Initiative Lowers Unnecessary Aspirin Use in Warfarin Users

Most Patient-Reported Outcome Measures in CVD Fall Short

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

New USPSTF Statin Guidance: Familiar Advice, Some Holes to Fill

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Few Cardiac Events Seen in College Athletes After COVID-19: ORCCA Registry

Good News and Bad for High-Intensity Statin Use in ASCVD

May 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content